Premia Global Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Premia Global Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$646K	Sell	5,218 -357	-6%	-$47.5K	1.11%	25
2019 Q2	$785K	Sell	5,575 -931	-14%	-$128K	1.23%	22
2019 Q1	$971K	Buy	+6,506	New	+$936K	0.98%	17
2018 Q4	–	Sell	-1,585	Closed	-$251K	–	29
2018 Q3	$251K	Buy	1,585 +914	+136%	+$138K	0.53%	23
2018 Q2	$91K	Buy	+671	New	+$92.1K	0.12%	69

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Premia Global Advisors's FBT Position: Q3 2019 in Review

Premia Global Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 6.4% in Q3 2019, selling an estimated $47.5K and leaving 5,218 shares worth $646K. The position accounts for 1.11% of the portfolio, ranked #25.

Premia Global Advisors first reported a position in FBT in Q2 2018 and has held it in 5 quarters since. The position peaked at $971K in Q1 2019. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

Premia Global Advisors held 5,218 shares of First Trust NYSE Arca Biotechnology Index Fund worth $646K as of Q3 2019.
Premia Global Advisors sold 357 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $47.5K.
First Trust NYSE Arca Biotechnology Index Fund made up 1.11% of Premia Global Advisors's portfolio in Q3 2019, its #25 holding.
Premia Global Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2018 and has held it in 5 quarters since.
Premia Global Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $971K in Q1 2019.
188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Premia Global Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.